3/7
11:24 am
tcrx
Rating for TCRX
Low
Report
Rating for TCRX
3/7
11:24 am
tcrx
Rating for TCRX
Low
Report
Rating for TCRX
3/6
11:54 am
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock, up previously from $9.00.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock, up previously from $9.00.
3/6
11:54 am
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock, up previously from $9.00.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock, up previously from $9.00.
2/26
05:39 pm
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Medium
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
2/26
05:39 pm
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Medium
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
2/1
10:35 am
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Medium
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
2/1
10:35 am
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Medium
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
2/1
10:01 am
tcrx
Rating for TCRX
Low
Report
Rating for TCRX
2/1
10:01 am
tcrx
Rating for TCRX
Low
Report
Rating for TCRX
1/4
06:32 pm
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
1/4
06:32 pm
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.